CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475461709
- Phone
- (858) 684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-25 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2021-02-25 | Salter-Cid Luisa Chief Scientific Officer | Grant or award | +45,000 | 211,556 | ||
| 2021-02-25 | Salter-Cid Luisa Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2021-02-25 | Giraudo Bryan Chief Financial Officer | Grant or award | +45,000 | 115,379 | ||
| 2021-02-25 | Giraudo Bryan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2021-02-25 | Christian Waage EVP & General Counsel | Grant or award | +45,000 | 593,689 | ||
| 2021-02-25 | Christian Waage EVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2020-10-14 | Christian Waage EVP & General Counsel | Purchase | +2,500 | $9.53 | $24K | 6,954 |
| 2020-10-14 | Hasnain Faheem Director | Purchase | +96,520 | $10.36 | $1000K | 3,478,629 |
| 2020-10-14 | Giraudo Bryan Chief Financial Officer | Purchase | +3,000 | $10.01 | $30K | 7,121 |
| 2020-06-23 | Giraudo Bryan Chief Financial Officer | Purchase | +2,000 | $12.96 | $26K | 4,121 |
| 2020-06-17 | GALA RENEE D Director | Grant or award · Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2020-06-17 | Daniel Thomas O Director | Grant or award · Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2020-06-17 | Cox Russell J. Director | Grant or award · Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2020-06-17 | Burow Kristina Director | Grant or award · Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2020-06-17 | Bilenker Joshua H. Director | Grant or award · Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2020-06-17 | Hasnain Faheem Director | Grant or award · Stock Option (right to buy) | +47,000 | 47,000 | ||
| 2020-02-14 | Dupont Jakob Chief Medical Officer | Grant or award | +46,500 | 46,500 | ||
| 2020-02-14 | Dupont Jakob Chief Medical Officer | Grant or award · Stock Option (right to buy) | +71,500 | 71,500 | ||
| 2020-02-14 | Salter-Cid Luisa Chief Scientific Officer | Grant or award | +46,500 | 166,556 |
Page 17 of 21 · 401 trades